OPHELIA O'SHEA: Open Payments
NPI 1639102338 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 34 payments from 6 companies in 2025. Trend: 2023 $117 · 2024 $351 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 25 | $209 |
| ABBVIE INC. | 5 | $116 |
| Medtronic, Inc. | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| BLUEWIND MEDICAL | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: GEMTESA, BOTOX, ALTAVIVA, JOURNAVX, REVI, Veozah.
Industry payments across TX — which companies pay providers there.
